Table 3.
Change in Medication Adherence between Baseline and 6 Months by Treatment Group
| Outcome | Control (n = 59) | Intervention (n = 60) | Between-group difference in change at 6 months (95% CI) | p value | ||
|---|---|---|---|---|---|---|
| Baseline | 6 months | Baseline | 6 months | |||
| Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | |||
| EMD medication adherence (% ± SD)a | 79.0 (23.6) | 72.4 (22.2) | 84.1 (26.8) | 74.5 (23.5) | − 3.0 (− 18.0 to 11.4) | 0.66 |
| Mean change | − 6.6% | − 9.6% | ||||
| Self-reported medication adherence (MMAS-8)a,b | 4.75 (1.14) | 6.01 (1.35) | 4.48 (1.41) | 6.46 (1.65) | 0.72 (0.07 to 1.39) | 0.03 |
| Mean change | + 1.26 | + 1.98 | ||||
Italic indicates statistical significance (p < 0.05)
aValues are estimated from the linear mixed effects regression models
EMD, electronic monitoring device
bMorisky Widget™, MMAS™, MMAS4™, MMAS-8™, Morisky Medication Adherence Protocol™, and Morisky Medication Adherence Scale™ content, name, and trademarks are protected by US and International Trademark and Copyright laws. Permission for use of the scale and its coding is required. A license agreement is available from Donald E. Morisky, ScD, ScM, MSPH, 14735 NE 20th St Bellevue, WA 98007, USA; dmorisky@gmail.com or Trubow1@gmail.com